Europe Tackles Huge Fraud Italian authorities and the European Anti-Fraud Office in Brussels, Belgium, have confirmed that they are prosecuting members of a large network accused of pocketing more than €50 million (US$72 million) in European Commission grants for fake research projects. [European Commission, European Union] European Medicines Agency and US Food and Drug Administration Receive First Parallel Quality-By-Design Application The European Medicines Agency and the United States Food and Drug Administration have agreed to accept the first application under their pilot program for the parallel evaluation of marketing-authorization applications involving ‘quality by design’. [European Medicines Agency, European Union] Egypt Invests in its Science On 1 June, the Egyptian Cabinet approved the first post-revolution budget, which boosted science despite the severe social and economic crises gripping the country. [Egyptian Cabinet, Egypt] NIH Expands Reach of National Clinical and Translational Research Consortium The National Institutes of Health (NIH) announced that it will provide $200 million over five years to five health research centers to speed scientific discoveries into treatments for patients. [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-14688) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-14689) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-14693) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-14716) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-14872) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-1473) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-15005) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-15012) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-15093) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-15095) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2011-15289) [National Institutes of Health, United States] Center for Scientific Review; Cancellation of Meeting (FR Doc No: 2011-14690) [National Institutes of Health, United States] Center for Scientific Review; Amended Notice of Meeting (FR Doc No: 2011-14694) [National Institutes of Health, United States] National Human Genome Research Institute; Notice of Closed Meeting (FR Doc No: 2011-14876) [National Institutes of Health, United States] National Human Genome Research Institute; Notice of Closed Meeting (FR Doc No: 2011-15011) [National Institutes of Health, United States] June 29, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Document [Center for Biologics Evaluation & Research, United States] June 29, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Draft Agenda [Center for Biologics Evaluation & Research, United States] Draft Guidance for Industry; Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology; Availability [Docket No. FDA-2010-D-0530] [Food and Drug Administration, United States] Draft Guidance for Industry on Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics; Availability [FR Doc No: 2011-15089] [Food and Drug Administration, United States] Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice [Docket No. FDA-2011-N-0447] [Food and Drug Administration, United States] |